Sponsor or institution
Clinical trials and research at K36 Therapeutics, Inc.
As of November 12, 2026, Find a Trial lists 2 clinical trials run by K36 Therapeutics, Inc. that are recruiting, at sites in 4 countries (most in United States (2), Canada (1), France (1)). By phase: Phase 1 (2). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 2Clinical trials
- 4Countries
All recruiting trials (2)
-
KTX-2001 (alone and with darolutamide) for men with metastatic castration‑resistant prostate cancer
This trial tests whether KTX-2001, by itself and combined with darolutamide, can help men whose prostate cancer has spread and stopped responding to hormone therapies.
-
Testing a new drug for patients with advanced multiple myeloma
This study is testing a new drug called KTX-1001 to see if it is safe and effective for adults with advanced multiple myeloma who have not responded to other treatments.
Quick answers
How many clinical trials run by K36 Therapeutics, Inc. are recruiting right now?
2, as of November 12, 2026. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 4 countries. The most sites are in United States (2 trials), Canada (1 trial), France (1 trial), Spain (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 2. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.